Tagged: Biophysics Graduate Program (BP)

Andrej Sali, PhD, has been elected as a member of the 2018 class of the National Academy of Sciences (NAS).

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.

A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut drug discovery time; Computational approaches target dopamine receptors; Researchers expose industry manipulation of science by sugar industry; Women in science; Bioengineering devices to treat glaucoma, diabetes, kidney disease; Campus activism on DACA; A helping hand to Puerto Rico, Basic science scholarship for women in developing nations; A decade of science camp; Honors and awards; 2017 Distinguished Alumnus of the Year; 2018 Mary Anne Koda-Kimble Seed Award for Innovation; 2018 Byers Award in Basic Science; Chan Zuckerberg Biohub Investigators; New faculty; Remembering C.C. Wang; UCSF fundraising campaign; Alumni Weekend 2018.

Babbitt's election as a 2018 ISCB fellow highlights her contributions to the fields of computational biology and bioinformatics.

Scientists identify a signature of cancers caused by mutant RAS that may lead to precise therapies.

Even with the best of microscopes, it's still a challenge to visualize the "inner life" of the cell.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.